Alterations in the MAPK [MAPK kinase (MEK)/ERK] signaling pathway, such as mutant BRAF, RAS, and RET fusions represent the majority of alterations in differentiated thyroid cancers and are key drivers in the progression of disease [9]. The gene discussed is MAP2K7; the disease is thyroid gland carcinoma.